Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Clinical Breast Cancer
|
December 28, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study
Alper Türkel, İlknur Deliktaş Onur, Anıl Karakayalı, et al.
Medicina (Kaunas, Lithuania)
|
May 4, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer
Ali Aytac, Bilgin Demir, Meltem Demirtas Gulmez, et al.
Value in Health Regional Issues
|
October 28, 2017
Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases: 1998--2015 Period in Turkey
Banu Bayar, Nurcan Uman Kutkan, Esra Şafak Yılmaz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 13, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG)
Ozden Demir, Bulent Cetin, Ali Alkan, et al.
Cancers
|
October 16, 2024
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study
Ebru Karci, Ahmet Bilici, Buket Bayram, et al.
Eclinicalmedicine
|
May 25, 2026
Psychometric properties and clinical utility of the EORTC QLQ-BM22 in patients with bone metastases: a systematic review
Nicole Wisener, Britney Zhang, Henry C Y Wong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 18, 2018
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Esin Oktay, Mustafa Levent, Hakan Gelincik, et al.
Scientific Reports
|
November 30, 2024
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, et al.
European Journal of Cancer Care
|
September 1, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, et al.
International Journal of Clinical Oncology
|
May 23, 2021
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Clinical Breast Cancer
|
December 28, 2025
Survival Outcomes and Recurrence Patterns of Early-Stage HER2-Positive Breast Cancer Patients on Adjuvant T-DM1 Treatment: Turkish Oncology Group (TOG) Study
Alper Türkel, İlknur Deliktaş Onur, Anıl Karakayalı, et al.
Medicina (Kaunas, Lithuania)
|
May 4, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer
Ali Aytac, Bilgin Demir, Meltem Demirtas Gulmez, et al.
Value in Health Regional Issues
|
October 28, 2017
Cost Evaluation of Inhaler Therapies Used in Respiratory Diseases: 1998--2015 Period in Turkey
Banu Bayar, Nurcan Uman Kutkan, Esra Şafak Yılmaz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
April 13, 2026
Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG)
Ozden Demir, Bulent Cetin, Ali Alkan, et al.
Cancers
|
October 16, 2024
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study
Ebru Karci, Ahmet Bilici, Buket Bayram, et al.
Eclinicalmedicine
|
May 25, 2026
Psychometric properties and clinical utility of the EORTC QLQ-BM22 in patients with bone metastases: a systematic review
Nicole Wisener, Britney Zhang, Henry C Y Wong, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
November 18, 2018
Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Esin Oktay, Mustafa Levent, Hakan Gelincik, et al.
Scientific Reports
|
November 30, 2024
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, et al.
European Journal of Cancer Care
|
September 1, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç, et al.
International Journal of Clinical Oncology
|
May 23, 2021
Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab
Deniz Tural, Ömer Fatih Ölmez, Ahmet Taner Sümbül, et al.
Page
of 12